Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage ...

Six strong recommendations developed, including initial management of dietary modifications and ensuring adequate fluid, fiber intake ...

A New Drug Application will be submitted to the Food and Drug Administration based on these results. Top-line results were announced from a phase 3 trial evaluating nerandomilast an oral, ...

The Food and Drug Administration (FDA) has approved Ebglyss™ (lebrikizumab-lbkz) for the treatment of adult and pediatric patients aged 12 years and older who weigh at least 40kg with moderate to ...

Lifetime use of standard statin increased QALYs by 0.24 to 0.70, with further increase seen for higher-intensity statins.

The Food and Drug Administration (FDA) has expanded the approval of Dupixent ® (dupilumab) to include add-on maintenance treatment of adolescent patients aged 12 to 17 years with inadequately ...

Veligrotug is an investigational monoclonal antibody that inhibits the activity of insulin-like growth factor-1 receptor.

HealthDay News — Statistics from 2023 on US obesity rates reveal that in every US state, 1 in every 5 people now has obesity, according to data released Thursday by the US Centers for Disease Control ...

The US Food and Drug Administration announced Tuesday that it will launch an independent review into any possible effects of toxic metals found in tampons.

The PURPOSE 1 study evaluated twice-yearly subcutaneous lenacapavir vs daily F/TDF for HIV preexposure prophylaxis.

Users take hearing tests on iPhones or iPads running iOS 18, and then their AirPods make "personalized dynamic adjustments" to allow them to hear.

HealthDay News — Immunotherapy (IO) utilization is increasing over time, but significant socioeconomic disparities exist for patients with advanced clear cell renal cell carcinoma (ccRCC) and ...